influenza A virus entry inhibitors (Chicago Biosolutions)

N/A

Report date: 2025/01/26 16:37:52
NME

Base Information

Drug Nameinfluenza A virus entry inhibitors (Chicago Biosolutions)
Drug Alias Namehemagglutinin inhibitors (Chicago BioSolutions)imidazo[1,2-alpha]pyrimidines as inhibitors targeting H3N2 and H7N1 influenza A group 2 hemagglutinins (Chicago BioSolutions)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInfluenza virus hemagglutinin glycoproteins inhibitors
TargetsInfluenza virus hemagglutinin glycoproteins
Therapy Area/IndicationsInfluenza A virus infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesChicago Biosolutions Inc
China Registration ClassN/A

Develop Information

Active CompaniesChicago Biosolutions Inc
Inactive CompaniesN/A
Active IndicationsInfluenza A virus infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A